is jardiance a glp-1 inhibitor Medication Options for Type 2 Diabetes What Drugs Should Not Be

With the rise of GLP-1 receptor agonists, we wanted to explore whether these treatments could reduce disease burden using real-world claims data. Researchers used propensity scores to match the groups with each other based on age, sex, race and comorbidities (type 2 diabetes, asthma, essential hypertension, hypercholesterolemia, hypertriglyceridemia and BMI)

essentially the immune systems mistakenly recognises pancreatic beta cells (The cells that release insulin in your body) as a foreign substance/organism, and therefore must be removed/killed from the body

Almeida et al

37.3 vs

encapsulated quercetin with modified silica nanoparticles and determined the release curve of quercetin through relevant experimental methods